These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7768775

  • 1. Effect of iron chelation on the in-vitro growth of Leishmania promastigotes.
    Soteriadou K, Papavassiliou P, Voyiatzaki C, Boelaert J.
    J Antimicrob Chemother; 1995 Jan; 35(1):23-9. PubMed ID: 7768775
    [Abstract] [Full Text] [Related]

  • 2. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect.
    Boelaert JR, Van Cutsem J, de Locht M, Schneider YJ, Crichton RR.
    Kidney Int; 1994 Mar; 45(3):667-71. PubMed ID: 8196268
    [Abstract] [Full Text] [Related]

  • 3. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ, Sheppard L, Hoffbrand AV, Charalambous J, Tikerpae J, Pippard MJ.
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conjugation to 4-aminoquinoline improves the anti-trypanosomal activity of Deferiprone-type iron chelators.
    Gehrke SS, Pinto EG, Steverding D, Pleban K, Tempone AG, Hider RC, Wagner GK.
    Bioorg Med Chem; 2013 Feb 01; 21(3):805-13. PubMed ID: 23266185
    [Abstract] [Full Text] [Related]

  • 6. Effect of desferrioxamine and deferiprone (L1) on the proliferation of MG-63 bone cells and on phosphatase alkaline activity.
    Naves Díaz ML, Elorriaga R, Canteros A, Cannata Andía JB.
    Nephrol Dial Transplant; 1998 Feb 01; 13 Suppl 3():23-8. PubMed ID: 9568816
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
    Chenoufi N, Hubert N, Loréal O, Morel I, Pasdeloup N, Cillard J, Brissot P, Lescoat G.
    J Hepatol; 1995 Aug 01; 23(2):166-73. PubMed ID: 7499788
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma.
    Srichairatanakool S, Thephinlap C, Phisalaphong C, Porter JB, Fucharoen S.
    Med Chem; 2007 Sep 01; 3(5):469-74. PubMed ID: 17897073
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.
    Hoyes KP, Porter JB.
    Br J Haematol; 1993 Oct 01; 85(2):393-400. PubMed ID: 8280612
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chelation of aluminium by combining DFO and L1 in rats.
    Blanusa M, Prester L, Varnai VM, Pavlović D, Kostial K, Jones MM, Singh PK.
    Toxicology; 2000 Jul 05; 147(3):151-6. PubMed ID: 10924797
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells.
    Simonart T, Boelaert JR, Mosselmans R, Andrei G, Noel JC, De Clercq E, Snoeck R.
    Gynecol Oncol; 2002 Apr 05; 85(1):95-102. PubMed ID: 11925126
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells.
    Link G, Pinson A, Hershko C.
    Blood; 1994 May 01; 83(9):2692-7. PubMed ID: 8167347
    [Abstract] [Full Text] [Related]

  • 20. Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals.
    Sheppard LN, Kontoghiorghes GJ.
    Arzneimittelforschung; 1993 Jun 01; 43(6):659-63. PubMed ID: 8352819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.